The Asthma and Allergy Foundation says more than 100 million people in the U.S. have asthma, a chronic inflammatory disease ...

Recommended management of asthma, including appropriate diagnostic steps and use of fractional exhaled nitric oxide (FeNO) in ...

Allergy and Clinical Immunology Division is marking World Allergy Week 2025 by highlighting the range of specialised services ...

Food allergies affect up to 10% of the population in the USA and have been increasing in prevalence over the last 2–3 ...

Beyond the classic symptoms of watery eyes and sniffles, there are more unusual ones, which can be mistaken for other things. Experts reveal what to look out for ...

Abstract Title: Improvement in Lung Function with Rademikibart in Eosinophilic Driven, Type 2 Asthma Abstract Number: 001678 Presenter: Rekha Chaudhuri, M.D. Session Title: Clinical Trials on ...

DRESS emphasize personalized care, topical therapies, and selective reintroduction protocols, offering hope for better ...

The identification of immune genes that distinguish patients with CRSwNP from healthy controls offers insight into disease ...

Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with ...

Harkavy, 4 in 1938, demonstrated local tissue eosinophilia in the area of a positive skin test to tobacco extract, indicating that this was strong evidence that the skin reaction was allergic.

The following is a summary of “Genetically Determined Inflammation-Related Proteins in Asthma and Type-2 Signatures,” published in the June 2025 issue of European Journal of Allergy and Clinical ...

Doctors and patients should rigorously evaluate diagnosis and treatment compliance before turning to biologics, two ...